Stevanato Group S.p.A (STVN) Non-Current Debt (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Non-Current Debt came in at $379.1 million in Q1 2026, up 14.94% year-on-year from $329.8 million in Q1 2025, and down 6.26% on a QoQ basis from $404.4 million in Q4 2025.
Stevanato Group S.p.A (STVN) Non-Current Debt (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Non-Current Debt data on file, last reported at $379.1 million in Q1 2026.
- On a quarterly basis, Non-Current Debt rose 14.94% year-over-year to $379.1 million in Q1 2026; TTM through Mar 2026 was $379.1 million, a 14.94% increase from a year earlier, with the FY2025 full-year figure at $404.4 million, up 219.1% from the prior year.
- Non-Current Debt for Q1 2026 stood at $379.1 million, down from $404.4 million in the prior quarter.
- Over the last five years, Non-Current Debt for STVN reached as high as $430.3 million in Q3 2025 and fell as low as -$339.5 million in Q4 2024.
- Historically, Non-Current Debt has averaged $184.7 million across 5 years, with a median of $221.4 million in 2022.
- Across the five-year window, Non-Current Debt tumbled 81.64% in 2023 and surged 219.1% in 2025, its largest moves.
- Year by year, Non-Current Debt stood at -$151.4 million in 2022, then tumbled by 81.64% to -$275.0 million in 2023, then dropped by 23.45% to -$339.5 million in 2024, then jumped by 219.1% to $404.4 million in 2025, then retreated by 6.26% to $379.1 million in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $379.1 million in Q1 2026, $404.4 million in Q4 2025, and $430.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 4.16 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 14.71 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 12.50 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 404.17 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.86 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.58 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | 379.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 379.05 Mn |
| Dec 31, 2025 | 404.35 Mn |
| Sep 30, 2025 | 430.31 Mn |
| Jun 30, 2025 | 387.85 Mn |
| Mar 31, 2025 | 329.79 Mn |
| Dec 31, 2024 | -339.49 Mn |
| Sep 30, 2024 | 317.79 Mn |
| Jun 30, 2024 | 271.78 Mn |
| Mar 31, 2024 | 304.76 Mn |
| Dec 31, 2023 | -275.01 Mn |
| Sep 30, 2023 | 213.70 Mn |
| Jun 30, 2023 | 131.62 Mn |
| Mar 31, 2023 | 153.78 Mn |
| Dec 31, 2022 | -151.40 Mn |
| Sep 30, 2022 | 172.23 Mn |
| Jun 30, 2022 | 187.21 Mn |
| Mar 31, 2022 | 221.36 Mn |
| Dec 31, 2021 | -231.43 Mn |
| Sep 30, 2021 | 279.62 Mn |
| Jun 30, 2021 | 318.59 Mn |